The
cofounder of AlphaMol Dr. Shuguang Yuan was invited to join the
international GPCR conference in Lugano during Sep. 12-14 in
Switzerland. He gave a talked entitled "Advancing GPCR modern
drug discovery via molecular pharmacology and computational methods",
to present AlphaMol's latest progresses in GPCR basic research and
drug discovery.
There are more than 100 scientists from 14
different countries joint this event. These included Brian Kobilka
(Stanford University, the Nobel Prize winner in 2013), Chris
Tate ( MRC Laboratory of Molecular Biology, Cambridge
University), Scott Prosser ( University of Toronto ), David
Gloriam ( University of Copenhagen ), Peter Hildebrand (
Universität Leipzig ), Hugo Gutierrez De Teran ( Uppsala
University ), Edward Lyman ( University of Delaware ) and many
others.
This event bridged GPCR drug discovery and
latest progresses of computational biology. Representatives from
several big pharma also joint this event.
